Overall, our new findings highlight an antifibrotic role for SEMA3B and support modulating the SEMA3B-NRP1 axis as an innovative therapeutic approach to inhibit pulmonary fibrosis. This evidence concerns the gene SEMA3B and pulmonary fibrosis.